Kiniksa Pharmaceuticals Ltd at Goldman Sachs Global Healthcare Conference Transcript
Okay, great. Thanks for joining us. I'm Terence Flynn, one of the biotech analysts here at Goldman Sachs. And we're very pleased to have Kiniksa joining us this afternoon. From the company, we have Sanj Patel, Chairman and CEO; and John Paolini, who is the Chief Medical Officer. Thank you very much both for joining us, really appreciate you taking the time to come out here.
Thank you.
Questions & Answers
Maybe to get started. Just because you guys are a relatively new company, would just love the kind of -- brief introduction to the company and the strategy and then just why the focus on autoimmune and inflammatory diseases. I think that's a great place to start before we dive into some of the pipeline catalysts, et cetera.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
